All In MedTech

Device Trial Radar · NCT06043544

Hymovis® Intra-articular Injections vs Corticosteroids Intra-articular Injections in Patients Affected by Glenohumeral Osteoarthritis:

Hymovis® Intra-articular Injections vs Corticosteroids Intra-articular Injections in Patients Affected by Glenohumeral Osteoarthritis: a Monocentric Randomized Open-label Trial

Last checked: Nov 19, 2026Latest source record: Sep 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

80

Actual

Start

May 2, 2021

Primary completion

Nov 10, 2021

Study completion Mar 31, 2022

Sponsor

Lead sponsor
Concordia Hospital RomeAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 21, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 40 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This monocentric randomized open-label study aims to assess the efficacy and safety of a treatment with medium molecular weight hyaluronic acid (HA) compared to a treatment with corticosteroids on patients affected by glenohumeral osteoarthritis.

Conditions

  • Glenohumeral Osteoarthritis

Interventions

  • Hyaluronic Acid 24 MG in 3 mL Prefilled SyringeDevice

    Patients in the treatment group received two intra-articular injections with Hymovis® (24mg/3ml) a week apart from each other

  • Corticosteroid injectionDrug

    Patients in control group received two intra-articular injections with corticosteroids a week apart from each other.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate the pain reduction in the target shoulder compared to control groupTime frame: At 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Concordia Hospital

    Rome, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.